Hansa Biopharma Expects Strong First Quarter 2024 Sales Performance

Company expects revenue of SEK 54m including product sales of SEK 48m – an increase of 10% versus the prior quarter and a 234% increase versus Q1 2023 Q1 2024 is the first time Hansa has delivered two consecutive quarters of strong revenue and growth LUND, Sweden, April 2, 2024…